Wolverine Trading’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18M | Buy |
129,600
+31,300
| +32% | +$4.23M | 0.01% | 640 |
|
|
2025
Q2 | $12.4M | Buy |
98,300
+26,300
| +37% | +$3.28M | 0.01% | 627 |
|
|
2025
Q1 | $9.96M | Buy |
72,000
+20,100
| +39% | +$2.87M | 0.01% | 645 |
|
|
2024
Q4 | $7.79M | Buy |
51,900
+27,900
| +116% | +$4.71M | 0.01% | 920 |
|
|
2024
Q3 | $4.67M | Buy |
24,000
+5,700
| +31% | +$1.19M | ﹤0.01% | 1085 |
|
|
2024
Q2 | $4.24M | Sell |
18,300
-300
| -2% | -$65.2K | ﹤0.01% | 1077 |
|
|
2024
Q1 | $4.01M | Sell |
18,600
-3,200
| -15% | -$749K | ﹤0.01% | 1150 |
|
|
2023
Q4 | $5.64M | Buy |
21,800
+100
| +0.5% | +$24.6K | 0.01% | 1024 |
|
|
2023
Q3 | $5.58M | Sell |
21,700
-13,900
| -39% | -$3.72M | 0.01% | 933 |
|
|
2023
Q2 | $10M | Buy |
35,600
+4,600
| +15% | +$1.37M | 0.01% | 589 |
|
|
2023
Q1 | $8.53M | Sell |
31,000
-27,100
| -47% | -$7.5M | 0.01% | 600 |
|
|
2022
Q4 | $16.1M | Sell |
58,100
-56,000
| -49% | -$15.8M | 0.02% | 460 |
|
|
2022
Q3 | $30.2M | Buy |
114,100
+40,500
| +55% | +$8.6M | 0.05% | 214 |
|
|
2022
Q2 | $15.1M | Buy |
73,600
+8,900
| +14% | +$1.82M | 0.03% | 387 |
|
|
2022
Q1 | $13.7M | Sell |
64,700
-5,100
| -7% | -$1.11M | 0.02% | 573 |
|
|
2021
Q4 | $16.8M | Buy |
69,800
+5,600
| +9% | +$1.44M | 0.02% | 521 |
|
|
2021
Q3 | $18.3M | Sell |
64,200
-62,500
| -49% | -$20.5M | 0.02% | 561 |
|
|
2021
Q2 | $43.8M | Buy |
126,700
+67,500
| +114% | +$20.4M | 0.07% | 207 |
|
|
2021
Q1 | $16.3M | Sell |
59,200
-19,300
| -25% | -$5.2M | 0.02% | 477 |
|
|
2020
Q4 | $19.1M | Buy |
78,500
+13,700
| +21% | +$3.53M | 0.03% | 415 |
|
|
2020
Q3 | $18.3M | Sell |
64,800
-11,600
| -15% | -$3.24M | 0.04% | 330 |
|
|
2020
Q2 | $19.9M | Buy |
76,400
+9,700
| +15% | +$2.92M | 0.05% | 255 |
|
|
2020
Q1 | $21.1M | Sell |
66,700
-62,300
| -48% | -$18.9M | 0.06% | 209 |
|
|
2019
Q4 | $38.2M | Buy |
129,000
+19,100
| +17% | +$5.3M | 0.09% | 163 |
|
|
2019
Q3 | $25.3M | Sell |
109,900
-49,900
| -31% | -$11.6M | 0.07% | 215 |
|
|
2019
Q2 | $37.4M | Sell |
159,800
-77,000
| -33% | -$17.8M | 0.11% | 131 |
|
|
2019
Q1 | $56M | Buy |
236,800
+80,200
| +51% | +$25.3M | 0.16% | 71 |
|
|
2018
Q4 | $46M | Sell |
156,600
-4,400
| -3% | -$1.4M | 0.13% | 97 |
|
|
2018
Q3 | $56.9M | Buy |
161,000
+51,600
| +47% | +$17.8M | 0.12% | 89 |
|
|
2018
Q2 | $30M | Hold |
109,400
| – | – | 0.07% | 168 |
|
|
2018
Q1 | $30M | Sell |
109,400
-38,000
| -26% | -$11.8M | 0.07% | 168 |
|
|
2017
Q4 | $47M | Sell |
147,400
-6,700
| -4% | -$2.15M | 0.17% | 90 |
|
|
2017
Q3 | $48.3M | Buy |
154,100
+71,200
| +86% | +$21.1M | 0.18% | 83 |
|
|
2017
Q2 | $22.5M | Buy |
+82,900
| New | +$21.9M | 0.1% | 174 |
|
|
2017
Q1 | – | Sell |
-138,300
| Closed | -$39.2M | – | 4255 |
|
|
2016
Q4 | $39.2M | Buy |
+138,300
| New | +$41M | 0.19% | 96 |
|
|
2016
Q3 | – | Sell |
-101,000
| Closed | -$24.1M | – | 4592 |
|
|
2016
Q2 | $24.1M | Buy |
+101,000
| New | +$26.6M | 0.14% | 138 |
|
Other funds holding BIIB
Wolverine Trading's BIIB Position: Q3 2025 in Review
Wolverine Trading sold out of Biogen (BIIB) in Q3 2025, closing a stake of 6,667 shares — an estimated $901K sold.
Wolverine Trading first reported a position in BIIB in Q2 2016 and held it in 33 quarters. The position peaked at $11.7M in Q3 2019. 905 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.
- Wolverine Trading reported no remaining Biogen position as of Q3 2025 after selling out during the quarter.
- Wolverine Trading sold 6,667 Biogen shares in Q3 2025, an estimated $901K.
- Wolverine Trading first reported a position in Biogen in Q2 2016 and held it in 33 quarters.
- Wolverine Trading's Biogen position peaked at $11.7M in Q3 2019.
- 905 funds tracked by Wall St. Rank held Biogen as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.